Drug class
Active metabolite of fesoterodine; muscarinic acetylcholine receptor antagonist
Mechanism of action
The active metabolite 5-hydroxymethyltolterodine competitively antagonises muscarinic receptors on bladder detrusor smooth muscle, reducing acetylcholine-mediated involuntary contractions and increasing functional bladder capacity.
General use cases
- The clinically marketed prodrug fesoterodine is used for overactive bladder in adults and selected paediatric patients. Desfesoterodine is the active metabolite and is not usually marketed as an independent API; do not assign it a separate standalone indication.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
